セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/25 | 3,645 | 3,775 | 3,585 | 3,680 | +35 | +1% | 199,900 |
| 2023/01/24 | 3,565 | 3,650 | 3,525 | 3,645 | +145 | +4.1% | 156,600 |
| 2023/01/23 | 3,410 | 3,510 | 3,370 | 3,500 | +100 | +2.9% | 137,500 |
| 2023/01/20 | 3,460 | 3,475 | 3,390 | 3,400 | -95 | -2.7% | 181,800 |
| 2023/01/19 | 3,590 | 3,590 | 3,470 | 3,495 | -65 | -1.8% | 128,300 |
| 2023/01/18 | 3,555 | 3,645 | 3,535 | 3,560 | ±0 | ±0% | 125,100 |
| 2023/01/17 | 3,650 | 3,650 | 3,540 | 3,560 | -120 | -3.3% | 126,000 |
| 2023/01/16 | 3,555 | 3,725 | 3,555 | 3,680 | +80 | +2.2% | 131,100 |
| 2023/01/13 | 3,620 | 3,620 | 3,480 | 3,600 | -10 | -0.3% | 188,500 |
| 2023/01/12 | 3,650 | 3,700 | 3,595 | 3,610 | -10 | -0.3% | 102,100 |
| 2023/01/11 | 3,675 | 3,725 | 3,620 | 3,620 | -20 | -0.5% | 162,100 |
| 2023/01/10 | 3,700 | 3,725 | 3,560 | 3,640 | +5 | +0.1% | 154,800 |
| 2023/01/06 | 3,645 | 3,680 | 3,580 | 3,635 | -60 | -1.6% | 123,200 |
| 2023/01/05 | 3,740 | 3,780 | 3,655 | 3,695 | -40 | -1.1% | 141,900 |
| 2023/01/04 | 3,880 | 3,940 | 3,700 | 3,735 | -270 | -6.7% | 212,400 |
| 2022/12/30 | 3,875 | 4,115 | 3,860 | 4,005 | +170 | +4.4% | 211,400 |
| 2022/12/29 | 3,870 | 3,950 | 3,820 | 3,835 | -40 | -1% | 131,200 |
| 2022/12/28 | 3,920 | 3,970 | 3,835 | 3,875 | -60 | -1.5% | 131,000 |
| 2022/12/27 | 3,805 | 3,985 | 3,790 | 3,935 | +165 | +4.4% | 222,500 |
| 2022/12/26 | 3,860 | 3,880 | 3,730 | 3,770 | -80 | -2.1% | 179,800 |
| 2022/12/23 | 4,120 | 4,185 | 3,850 | 3,850 | -335 | -8% | 264,000 |
| 2022/12/22 | 4,245 | 4,270 | 4,115 | 4,185 | -25 | -0.6% | 110,300 |
| 2022/12/21 | 4,340 | 4,355 | 4,120 | 4,210 | -160 | -3.7% | 274,400 |
| 2022/12/20 | 4,590 | 4,665 | 4,300 | 4,370 | -265 | -5.7% | 276,700 |
| 2022/12/19 | 4,350 | 4,635 | 4,350 | 4,635 | +105 | +2.3% | 217,500 |
| 2022/12/16 | 4,225 | 4,585 | 4,215 | 4,530 | +230 | +5.3% | 700,900 |
| 2022/12/15 | 4,900 | 5,080 | 4,150 | 4,300 | -800 | -15.7% | 2,112,900 |
| 2022/12/14 | 4,935 | 5,210 | 4,915 | 5,100 | +260 | +5.4% | 434,000 |
| 2022/12/13 | 4,800 | 4,875 | 4,775 | 4,840 | +100 | +2.1% | 117,600 |
| 2022/12/12 | 4,840 | 4,850 | 4,730 | 4,740 | -170 | -3.5% | 129,500 |
| 2022/12/09 | 4,840 | 4,935 | 4,830 | 4,910 | +70 | +1.4% | 112,400 |
| 2022/12/08 | 4,820 | 4,855 | 4,720 | 4,840 | +20 | +0.4% | 77,700 |
| 2022/12/07 | 4,865 | 4,865 | 4,620 | 4,820 | -115 | -2.3% | 197,600 |
| 2022/12/06 | 5,000 | 5,030 | 4,930 | 4,935 | -115 | -2.3% | 95,400 |
| 2022/12/05 | 5,020 | 5,050 | 4,955 | 5,050 | +30 | +0.6% | 75,600 |
| 2022/12/02 | 4,950 | 5,080 | 4,940 | 5,020 | +45 | +0.9% | 89,900 |
| 2022/12/01 | 5,200 | 5,230 | 4,960 | 4,975 | -75 | -1.5% | 142,700 |
| 2022/11/30 | 5,010 | 5,120 | 4,980 | 5,050 | -20 | -0.4% | 91,300 |
| 2022/11/29 | 4,975 | 5,100 | 4,935 | 5,070 | +70 | +1.4% | 61,100 |
| 2022/11/28 | 4,935 | 5,140 | 4,920 | 5,000 | +30 | +0.6% | 93,200 |
| 2022/11/25 | 4,990 | 5,050 | 4,950 | 4,970 | ±0 | ±0% | 104,700 |
| 2022/11/24 | 4,785 | 4,990 | 4,785 | 4,970 | +205 | +4.3% | 180,400 |
| 2022/11/22 | 4,675 | 4,795 | 4,605 | 4,765 | +65 | +1.4% | 94,500 |
| 2022/11/21 | 4,690 | 4,830 | 4,675 | 4,700 | +40 | +0.9% | 102,500 |
| 2022/11/18 | 4,700 | 4,820 | 4,630 | 4,660 | -90 | -1.9% | 83,600 |
| 2022/11/17 | 4,510 | 4,750 | 4,505 | 4,750 | +260 | +5.8% | 192,900 |
| 2022/11/16 | 4,540 | 4,595 | 4,395 | 4,490 | -50 | -1.1% | 150,400 |
| 2022/11/15 | 4,540 | 4,650 | 4,530 | 4,540 | -70 | -1.5% | 97,500 |
| 2022/11/14 | 4,500 | 4,630 | 4,460 | 4,610 | +110 | +2.4% | 125,800 |
| 2022/11/11 | 4,410 | 4,515 | 4,305 | 4,500 | +240 | +5.6% | 223,800 |
451～
500
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
